USPTO serial 74687503
NANOSOL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 22, 1996
- Examiner
- DELANEY, ZHALEH SYBIL
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with NANOSOL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
69120 Heidelberg, DE
69120 Heidelberg, DE
69120 Heidelberg, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
LAWRENCE E. ABELMAN
LAWRENCE E ABELMAN ABELMAN FRAYNE & SCHWAB150 E 42ND STNEW YORK, NY 10017-5612UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations containing antibiotics, diuretics, and other pharmacological preparations for the treatment of diseases such as heart and cardiovascular diseases, pain and infectious diseases having inflammatory, rheumatic or other causes, diseases of the immunologic system, cough and colds, psychological diseases, and sugar diseases (e.g. diabetes); topical pharmaceutical preparations for the treatment of skin conditions and external wounds, namely wounds caused by burns, uv exposure and cuts; inflammatory skin diseases; allergic skin diseases; medicated skin creams and ointments; dietetic food supplements for medical purposes; vitamins, minerals, medicated bath salts, medical teas, natural plant extracts to be used as dietary food supplements; pharmaceuticals for interior and exterior use containing pharmaceutically active substance preparations for the treatment of diseases such as heart and cardiovascular diseases, pain and infectious diseases having inflammatory, rheumatic or other causes, diseases of the immunologic system, coughs and colds, psychological dieases, and sugar diseases (e.g. diabetes); and for the treatment of skin diseases, namely wounds caused by burns, uv exposure and cuts; inflammatory skin diseases; allergic skin diseases | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 26, 2003 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 4, 1998 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Jun 19, 1998 | AMD7 | SEC 7 REQUEST FILED | — |
| Oct 22, 1996 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 30, 1996 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 28, 1996 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 17, 1996 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 4, 1996 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Apr 3, 1996 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Apr 3, 1996 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 14, 1996 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 4, 1995 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 24, 1995 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 14, 1995 | DOCK | ASSIGNED TO EXAMINER | — |